eXoZymes Earnings
NASDAQ: EXOZHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
2.91-0.475 (-14.05%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
eXoZymes earnings summary
In its most recent report on Nov 13, 2026 (Sep/2026), EXOZ posted EPS of $-0.24. Across the last 10 reports, EXOZ shares moved an average of 16.0% (in either direction) in the first trading session after results, rising 6 times and falling 4 times.
Summary generated from market data by MetaCap's automated system. Methodology
EXOZ earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Nov 13, 2026 | — | $-0.24 | — | -24.2% |
| Nov 12, 2026 | — | $-0.27 | — | -24.2% |
| Aug 13, 2026 | — | $-0.33 | — | +22.9% |
| May 14, 2026 | — | $-0.28 | — | +1.6% |
| Mar 30, 2026 | — | $-0.32 | — | +33.9% |
| Nov 13, 2025 | — | $-0.27 | — | +4.8% |
| Aug 12, 2025 | — | $-0.28 | — | -4.0% |
| May 12, 2025 | — | $-0.22 | — | -0.9% |
| Mar 31, 2025 | — | $-0.24 | — | +9.5% |
| Nov 12, 2024 | — | $-0.27 | — | +34.0% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.